157 related articles for article (PubMed ID: 18695662)
1. Myelofibrosis as the initial presentation of donor-derived myelodysplastic syndrome/AML: failure of a lasting response to a second allogeneic transplant from the original donor.
Cutting RJ; Welch E; Channer J; Ezaydi Y; Talley P; Reilly JT; Snowden JA
Bone Marrow Transplant; 2008 Nov; 42(9):631-3. PubMed ID: 18695662
[No Abstract] [Full Text] [Related]
2. Donor cell-derived myelodysplastic syndrome in a patient 7 years after unrelated allogeneic HLA-mismatched transplantation for Ph+ chronic myeloid leukemia.
Kraut L; Trebeljahr G; Thiele B; Fauser AA
Bone Marrow Transplant; 2005 Oct; 36(8):737. PubMed ID: 16086042
[No Abstract] [Full Text] [Related]
3. Development of BCR-ABL positive acute lymphoblastic leukemia in donor cells after allogeneic hematopoietic cell transplantation for Philadelphia-positive acute lymphoblastic leukemia.
Athanasiadou A; Stamatopoulos K; Sakellari I; Zorbas I; Gaitatzi M; Fassas A; Anagnostopoulos A
Bone Marrow Transplant; 2004 Jul; 34(2):189-91. PubMed ID: 15156167
[No Abstract] [Full Text] [Related]
4. Donor cell-derived leukemia and myelodysplastic neoplasm: unique forms of leukemia.
Sala Torra O; Loeb KR
Am J Clin Pathol; 2011 Apr; 135(4):501-4. PubMed ID: 21411772
[No Abstract] [Full Text] [Related]
5. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
[TBL] [Abstract][Full Text] [Related]
6. Recurring diagnostic problems in the pathology of the myelodysplastic syndromes.
Rosati S; Anastasi J; Vardiman J
Semin Hematol; 1996 Apr; 33(2):111-26. PubMed ID: 8722682
[No Abstract] [Full Text] [Related]
7. Second allogeneic stem cell transplantation in myeloid malignancies.
Hartwig M; Ocheni S; Asenova S; Wiedemann B; Zabelina T; Ayuk F; Kabisch H; Erttmann R; Kröger N; Zander AR; Bacher U
Acta Haematol; 2009; 122(4):185-92. PubMed ID: 19887774
[TBL] [Abstract][Full Text] [Related]
8. Myelodysplastic and myeloproliferative disorders in children.
Hasle H
Curr Opin Pediatr; 2007 Feb; 19(1):1-8. PubMed ID: 17224655
[TBL] [Abstract][Full Text] [Related]
9. Donor-cell MDS in a 12-year-old girl 3 years after allogeneic hematopoietic SCT for MDS, both with a t(3;3)(q21;q26) cytogenetic aberration.
Leguit RJ; van den Berg H; Buijs A; Mellink C; Bierings M
Bone Marrow Transplant; 2011 Jun; 46(6):908-10. PubMed ID: 20838388
[No Abstract] [Full Text] [Related]
10. Differences in proportion and dynamics of recipient hematopoiesis following hematopoietic cell transplantation in CML and IMF.
Siebolts U; Thiele J; Zander T; Ditschkowski M; Beelen DW; Kröger N; Fehse B; Wickenhauser C
Oncol Rep; 2008 Jan; 19(1):287-92. PubMed ID: 18097609
[TBL] [Abstract][Full Text] [Related]
11. Demodicidosis as a cause of facial eruption developing early after allogeneic hematopoietic stem cell transplantation.
Aisa Y; Mori T; Tanikawa A; Takae Y; Kato J; Ikeda Y; Okamoto S
Transpl Int; 2008 Dec; 21(12):1192-3. PubMed ID: 18783387
[No Abstract] [Full Text] [Related]
12. Reticulated platelets as a marker of platelet recovery after allogeneic stem cell transplantation.
Michur H; Maślanka K; Szczepiński A; Mariańska B
Int J Lab Hematol; 2008 Dec; 30(6):519-25. PubMed ID: 18983304
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic stem cell transplantation for chronic myeloid leukemia-status in 2007.
Goldman J
Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S11-S13. PubMed ID: 18724281
[TBL] [Abstract][Full Text] [Related]
14. Donor cell-derived myelodysplastic syndrome after cord blood transplantation.
Konuma T; Ooi J; Takahashi S; Tomonari A; Tsukada N; Kato S; Sato A; Monma F; Hongo E; Uchimaru K; Tojo A; Asano S
Bone Marrow Transplant; 2009 Mar; 43(5):429-31. PubMed ID: 18978827
[No Abstract] [Full Text] [Related]
15. The use of blood conservation methods in addition to erythropoietin allows myeloablative allogeneic stem cell transplantation without the use of blood products.
Ciurea S; Beri R; Dobogai L; Chunduri S; Mahmud N; Rondelli D; Peace D
Bone Marrow Transplant; 2006 Feb; 37(3):325-7. PubMed ID: 16314850
[No Abstract] [Full Text] [Related]
16. Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
Patriarca F; Bacigalupo A; Sperotto A; Isola M; Soldano F; Bruno B; van Lint MT; Iori AP; Santarone S; Porretto F; Pioltelli P; Visani G; Iacopino P; Fanin R; Bosi A;
Haematologica; 2008 Oct; 93(10):1514-22. PubMed ID: 18728030
[TBL] [Abstract][Full Text] [Related]
17. Donor-derived myelodysplastic syndrome after allogeneic stem cell transplantation in a family with germline GATA2 mutation.
Sakata N; Okano M; Masako R; Tanaka A; Yamashita Y; Karasuno T; Imadome KI; Okada M; Sugimoto K
Int J Hematol; 2021 Feb; 113(2):290-296. PubMed ID: 32865708
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic cell transplantation from an HLA-mismatched familial donor is feasible without ex vivo-T cell depletion after reduced-intensity conditioning with busulfan, fludarabine, and antithymocyte globulin.
Lee KH; Lee JH; Lee JH; Kim DY; Kim SH; Shin HJ; Lee YS; Kang YA; Seol M; Ryu SG
Biol Blood Marrow Transplant; 2009 Jan; 15(1):61-72. PubMed ID: 19135944
[TBL] [Abstract][Full Text] [Related]
19. Imatinib use either pre- or post-allogeneic hematopoietic cell transplantation (allo-HCT) does not increase cardiac toxicity in chronic myelogenous leukemia patients.
Burke MJ; Trotz B; Luo X; Weisdorf DJ; Baker KS; Wagner JE; Verneris MR
Bone Marrow Transplant; 2009 Aug; 44(3):169-74. PubMed ID: 19204709
[TBL] [Abstract][Full Text] [Related]
20. A fatal Clostridium infection in an allogeneic stem cell transplant recipient.
Jain M; Titanji R; Rapoport AP; Wang W; Gocke C; Cross A; Akpek G
Bone Marrow Transplant; 2005 Sep; 36(5):455-7. PubMed ID: 15995716
[No Abstract] [Full Text] [Related]
[Next] [New Search]
